DIA 2014 50th Annual Meeting to Explore Regulatory Challenges for Orphan Medicines

  DIA 2014 50th Annual Meeting to Explore Regulatory Challenges for Orphan
  Medicines

   Symposium to highlight how legislation in Europe and U.S. can help bring
                             medicines to market

DIA 2014

Business Wire

WASHINGTON -- April 21, 2014

“Regulatory Challenges for Orphan Medicines,” a symposium that features
presentations by a number of industry experts, will take place during the DIA
2014 50th Annual Meeting at the San Diego Convention Center from June 15 to
19.

The symposium, held June 18 at 3:30 p.m., will focus on the regulatory
environment and trends for orphan medicinal products around the world.
Discussions will also include how companies can use the orphan drug
legislation in Europe and the U.S. to support development of these products
for markets outside of International Conference on Harmonisation regions.

“Our annual meeting is a global platform that offers holistic and integrated
approaches for the life cycle management of regulated health care products,”
said Barbara L. Kunz, DIA global chief executive. “This symposium embodies our
approach by uniting diverse perspectives to better inform our members of how
to bring orphan medicines to patients.”

The symposium includes an industry perspective of the regulatory challenges
and opportunities for global development of orphan medicinal products given by
Martine Zimmermann, vice president of global regulatory affairs for Alexion
Pharmaceuticals, Inc. Isabel Zwart, senior regulatory consultant for Parexel,
will discuss the role of orphan drug legislation in emerging markets, and Dr.
Jordi Llinares, head of product development scientific support for the
European Medicines Agency, will conclude with his perspective of the
regulatory challenges for orphan medicines.

ABOUT DIA:DIA is the global connector in the life sciences product
development process. Our association of more than 18,000 members builds
productive relationships by bringing together regulators, innovators and
influencers to exchange knowledge and collaborate in an impartial setting.
DIA’s network creates unparalleled opportunities for the exchange of knowledge
and has the interdisciplinary experience to prepare for future developments.
DIA is an independent, nonprofit organization with its global center in
Washington, D.C., USA; regional offices covering North and South America
(Horsham, Pa., USA); Europe, North Africa and the Middle East (Basel,
Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more
information, visitwww.diahome.org.

ABOUT DIA’s 2014 50th ANNUAL MEETING:Celebrate the Past – Invent the Future
is the largest multidisciplinary event that brings together a community of
life sciences professionals at all levels and across all disciplines involved
in the discovery, development and life cycle management of medical products.
The meeting aims to foster innovation that will lead to the development of
safe and effective medical products and therapies for patients.For more
information, visitwww.diahome.org/dia2014.

Contact:

DIA
Tiffany Cohen, 202-499-4411
tcohen@reingold.com
 
Press spacebar to pause and continue. Press esc to stop.